Abstract: A system and method for trialing a modular hip replacement system permits evaluation and replication of the anatomic anteversion rotational angle of the femur. In one embodiment, a femoral hip implant kit includes at least one distal implant and a plurality of femoral heads, each of the plurality of femoral heads having a diameter different from the diameter of the other of the plurality of femoral heads. The kit includes a proximal trial housing with a bore within the housing, the bore configured to receive a portion of the distal implant, a collet located within the bore, the collet including an outer wall portion extending between a top surface portion and a bottom surface portion, a collapsing member for engaging the portion of the distal implant and for forcing the top surface portion of the collet toward the bottom surface portion of the collet along a first axis.

Abstract: A system and method for trialing a modular hip replacement system permits evaluation and replication of the anatomic anteversion rotational angle of the femur. In one embodiment, a femoral hip implant kit includes at least one distal implant and a plurality of femoral heads, each of the plurality of femoral heads having a diameter different from the diameter of the other of the plurality of femoral heads. The kit includes a proximal trial housing with a bore within the housing, the bore configured to receive a portion of the distal implant, a collet located within the bore, the collet including an outer wall portion extending between a top surface portion and a bottom surface portion, a collapsing member for engaging the portion of the distal implant and for forcing the top surface portion of the collet toward the bottom surface portion of the collet along a first axis.

Abstract: A prosthetic trial for a joint prosthesis includes a stem having a proximal section and a distal section for implantation in a bone. A body includes a channel receiving at least the proximal section of the stem. A locking mechanism is at least partially disposed within the body. The locking mechanism is biased into a locking position in which the mechanism locks the stem within the first channel of the body. The locking mechanism is accessible outside said body to be pulled into a releasing position to unlock the stem from the body.

Abstract: A nutritional supplement composition for normalizing impaired or deteriorating neurological function in humans is composed of: at least one agent which promotes synthesis of ATP and/or creatine phosphate in the body, at least one antioxidant for scavenging free radicals in at least one pathway in the body; at least one agent for normalizing or maintaining membrane function and structure in the body; at least one agent for normalizing or maintaining normal neurotransmitter function in the body; at least one agent for down-regulating cortisol action; and at least one agent for suppressing activation of apoptotic pathways in the body.

Abstract: A combination of chemical agents reduces reductive stress by limiting the accumulation of high-energy electrons potentially available to the electron transport chain. A method of metabolic uncoupling therapy comprises: analyzing a specific physiologic process involving reductive stress; identifying a plurality of MUT agents that modulate metabolic pathways by influencing electron flux; and formulating a combination of MUT agents that limits the accumulation of high-energy electrons potentially available to the electron transport chain.

Abstract: A nutritional supplement composition for modulating nutrient partitioning in a human so as to increase oxidation of fat and promote increased storage of glycogen is composed of hydroxycitric acid, carnitine, biotin, a gluconeogenic substrate, and, optionally, one or more of chromium, conjugated linoleic acid, coenzyme Q10, eicosapentaenoic acid, pyridoxine, alpha-lipoic acid, magnesium, and gymnema sylvestre. A method for modulating nutrient partitioning in a human involves orally or parenterally administering the aforementioned composition to the human, preferably on a daily basis, for a therapeutically effective period of time. Preferably, the method further involves having the human follow a specific dietary regimen wherein the glycemic index is less than 60 and the daily calorie consumption from carbohydrates is less than about 50% and the daily calorie consumption from protein is at least about 20%.

Abstract: A nutritional supplement composition for normalizing impaired or deteriorating neurological function in humans is composed of: at least one agent which promotes synthesis of ATP and/or creatine phosphate in the body, at least one antioxidant for scavenging free radicals in at least one pathway in the body; at least one agent for normalizing or maintaining membrane function and structure in the body; at least one agent for normalizing or maintaining normal neurotransmitter function in the body; at least one agent for down-regulating cortisol action; and at least one agent for suppressing activation of apoptotic pathways in the body.

Abstract: A nutritional supplement composition for modulating nutrient partitioning in a human so as to increase oxidation of fat and promote increased storage of glycogen is composed of hydroxycitric acid, carnitine, biotin, a gluconeogenic substrate, and, optionally, one or more of chromium, conjugated linoleic acid, coenzyme Q10, eicosapentaenoic acid, pyridoxine, alpha-lipoic acid, magnesium, and gymnema sylvestre. A method for modulating nutrient partitioning in a human involves orally or parenterally administering the aforementioned composition to the human, preferably on a daily basis, for a therapeutically effective period of time. Preferably, the method further involves having the human follow a specific dietary regimen wherein the glycemic index is less than 60 and the daily calorie consumption from carbohydrates is less than about 50% and the daily calorie consumption from protein is at least about 20%.